Euro watchdogs: Sanofi obstructed probe

Apparently it's an antitrust kind of day: The European Commission announced it's investigating Sanofi-Aventis for obstructing its big probe of anticompetitive tactics in the drug industry. Europe's antitrust watchdog was raiding Sanofi's HQ in France when company officials refused to release documents without a search warrant from the French government. European law, however, requires companies to comply with E.C. inspectors.

You'll recall that in January, the E.C.'s antitrust cops raided a number of drugmakers in January, looking for evidence that their behavior in patenting new drugs and suing generics makers may have dampened competition.

- see the E.C.'s release
- get the Dow Jones story for more

Suggested Articles

With AbbVie's two most recent launches outperforming expectations, investors could be looking at a steal with an Allergan merger looming.

Investors are clamoring for a CVR created in the BMS-Celgene deal, but it will only pay off if the FDA approves three hot pipeline projects.

Muzammil Mansuri, Sanofi’s EVP of strategy and business development since February 2016, is retiring at the end of November.